Illumina Unveils TruSight™ Oncology 500 v2 for Comprehensive Genomic Profiling
Tagomics Partners with Agilent Technologies to Revolutionize Multiomic Biomarker Discovery
Bio-Techne Partners with Leader Life Sciences to Expand in the GCC Region
Owkin and Proscia Partner to Revolutionize MSI Testing for Colorectal Cancer with AI-Powered Solutions
Telix Expands Theranostic Pipeline with FAP-Targeting Radiopharmaceuticals
Alamar Biosciences and The Michael J. Fox Foundation Partner to Advance Parkinson’s Disease Biomarker Discovery
Stilla Technologies Partners with Source BioScience to Advance Genomics in the UK and Ireland
Quell Therapeutics and AstraZeneca Advance CAR-Treg Therapy for Type 1 Diabetes
AbbVie’s ELAHERE® Approved in the EU for Platinum-Resistant Ovarian Cancer
AstraZeneca’s Tagrisso Recommended for Approval in EU for Unresectable EGFR-Mutated NSCLC
Foundation Medicine Receives FDA Approval for FoundationOne®Liquid CDx as a Companion Diagnostic for TEPMETKO® in NSCLC
Exact Sciences Partners with Carlos Ponce to Boost Colorectal Cancer Awareness in the Hispanic Community
Merck Receives Positive CHMP Opinion for KEYTRUDA® in Combination Therapy for First-Line Treatment of Non-Epithelioid Mesothelioma
Australia Launches Genomics Australia to Lead Advances in Genomic Medicine
Sidra Medicine Unveils Masterclasses Ahead of PMFG 2024 Summit